CXCL8 and acute respiratory distress syndrome: In conclusion, this study was the first innovatively constructed EGFR and CXCL8 dual-responsive biomimetic particle-loaded miR-126a-3p for the treatment of ALI via inhibition of PIK3R2/NLRP3 signaling pathway and ferroptosis.